Blood test for cancer is trialled by NHS Scotland

The NHS in Scotland is to conduct a major screening trial for lung cancer using a new blood test developed by Oncimmune Ltd, a University of Nottingham spinout company. It will be the first time the blood test has been used outside the US.

Appears in issue 57

Tags: Chief Scientific Officer of Oncimmune Ltd, Director of CEAC, EarlyCDT-Lung, lung cancer, Oncimmune Ltd, Professor John Robertson, The Centre of Excellence for Autoimmunity in Cancer (CEAC)

Leading the revolution

The world’s first centre of excellence specialising in pioneering research into the early detection of cancer was being officially launched at the University’s School of Graduate Entry Medicine on 26 January.

Appears in Issue 54

Tags: Cancer, CEAC, Centre of Excellence for Autoimmunity in Cancer, EarlyCDT-Lung, Faculty of Medicine and Health Sciences, Impact: The Nottingham Campaign, International Agency for Research on Cancer, John Robertson, Oncimmune Ltd